Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients
Open Access
- 1 January 2020
- journal article
- research article
- Published by Informa UK Limited in Breast Cancer: Targets and Therapy
- Vol. 12, 27-35
- https://doi.org/10.2147/BCTT.S236483
Abstract
Purpose: Triple negative breast cancer (TNBC) accounts for approximately 15% of breast cancer cases and is associated with a poor prognosis. In this retrospective study of patients undergoing radiation therapy as part of their treatment, disease-free survival (DFS) and overall survival (OS) of TNBC patients were examined in relation to clinical and treatment-related factors. Patients and Methods: The electronic records of 214 consecutive TNBC patients treated with surgery followed by radiotherapy at the Mid North Coast Cancer Institute between 2006 and 2016 were reviewed. Overall survival and DFS times were analyzed using the Kaplan-Meier method; multivariate Cox proportional hazard regression modelling was used to assess the significance of prognostic factors. Results: The majority of tumors were T1 (51.9%), followed by T2 (39.2%) and T3 (6.1%). For the whole group, mean DFS was 106.4 (SD 48.7) months; OS 109.4 (SD 52.1) months. Radiotherapy technique, fractionation protocol and laterality were not significant factors for DFS or OS (p>0.05). However, compared to breast conservation, mastectomy was associated with poorer DFS (mean 114.2 vs 65.2 months; p 5cm and positive nodal status is associated with poorer DFS in TNBC patients. Radiotherapy technique or fractionation protocol were not associated with differences in DFS or OS in our patient cohort.Keywords
This publication has 25 references indexed in Scilit:
- The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 databaseOncotarget, 2016
- Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgeryStrahlentherapie und Onkologie, 2015
- The prognostic value of lymph node status among breast cancer subtypesThe American Journal of Surgery, 2015
- Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast CancerJournal of Breast Cancer, 2015
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsThe Lancet Oncology, 2013
- Triple negative breast cancer - prognostic factors and survivalRadiology and Oncology, 2011
- Triple-negative breast cancer: disease entity or title of convenience?Nature Reviews Clinical Oncology, 2010
- Triple-negative breast cancer: Novel therapies and new directionsMaturitas, 2009
- Is triple negative a prognostic factor in breast cancer?Breast Cancer, 2008
- Prognostic markers in triple‐negative breast cancerCancer, 2006